Bromodomain and extra-terminal domain (BET) family proteins have become a hot research area because of their close relationship with a variety of human diseases. The non-invasive imaging technique, such as positron emission tomography (PET), provides a powerful tool to visualize and quantify the BET family proteins that accelerating the investigation of this domain. Herein, we describe the development of a promising PET probe,[C-11]1, specifically targeting BET family proteins based on the potent BET inhibitor CF53.[C-11]1was successfully radio-synthesized with good yield and high purity after the optimization of radiolabeling conditions. Thein vivobio-activities evaluation of[C-11]1was performed using PET imaging in rodents. The results demonstrated that[C-11]1has favorable uptake in peripheral organs and moderate uptake in the brain. Further blocking studies indicated the high binding specificity and selectivity for BET proteins of this probe. Our findings suggest that[C-11]1is a promising BET PET probe for BET proteins as well as epigenetic imaging.